Board Representation Rules: Single vs Joint Representation Explained

Board Representation Rules: Single vs Joint Representation Explained

Company representation in Poland is the set of legal rules determining who can validly sign contracts and make binding declarations of will on behalf of a company. For international investors, these rules directly affect transaction enforceability, closing mechanics, and operational continuity – especially when dealing with a Polish limited liability company (sp. z o.o.) or a Polish joint-stock company (S.A.).

Why representation rules matter in Polish transactions

Polish law distinguishes between:

• Internal rules (how a company is managed internally), and
• External representation (who can bind the company towards third parties).

If the wrong person signs, the contract may be ineffective, may require later confirmation, or may trigger internal liability. In practice, representation errors often cause:

• closing delays (bank accounts, notarial deeds, share transfers),
• counterparty disputes about validity,
• compliance issues in regulated sectors, and
• reputational damage, particularly in M&A and crisis situations.

Basic rule: management board represents the company

In both a sp. z o.o. and an S.A., the management board (zarząd) is the default body authorized to represent the company externally. This follows from the Polish Commercial Companies Code (Kodeks spółek handlowych) – for a sp. z o.o. see Art. 201 and Art. 205; for an S.A. see Art. 368 and Art. 373 [1].

From a deal perspective, the key question is not “who is on the board,” but “what is the management board representation clause” disclosed in the commercial register (KRS). Counterparties typically verify this in KRS immediately before signing.

Single vs joint representation – what it means

Single representation

Single representation means that one board member can independently sign and bind the company. The representation clause will typically state that “each board member is entitled to represent the company individually.”

Business impact: single representation accelerates day-to-day contracting, but it increases governance risk if internal controls are weak (e.g., unauthorized commitments, fraud exposure, AML risk flags).

Joint representation

Joint representation means that binding declarations require cooperation of two persons, most commonly:

• two management board members acting together, or
• one management board member acting jointly with a commercial proxy (prokurent).

This is a common structure for joint representation sp z oo setups. Business impact: it strengthens control and reduces single-person risk, but it can slow execution, especially in cross-border settings and when signatories travel frequently.

Who can sign contracts Poland company – the three exceptions that frequently confuse counterparties

As a rule, the KRS representation clause governs who can sign. However, transaction practice requires attention to three recurring exceptions that often cause misunderstandings or incorrect assumptions:

Exception 1: Internal limits do not affect third parties (as a rule)

Even if internal corporate documents or resolutions impose restrictions (e.g., requiring supervisory board consent, shareholder consent, or internal spending caps), such internal restrictions generally do not affect the validity of acts performed towards third parties, unless a specific statute provides otherwise. This principle follows from the Commercial Companies Code rules separating representation from internal management and consent mechanisms (e.g., Art. 17 and Art. 230 for sp. z o.o.; Art. 17 and Art. 393 for S.A., depending on the matter) [1].

Correction/clarification (statutory exception): where an act requires a resolution by law (e.g., certain transactions listed in Art. 230 or Art. 393 CCC, if the given case falls within the provision), the absence of the required resolution may affect the company’s ability to validly perform the act under the CCC regime, and its consequences are assessed under the applicable statutory rules rather than treated solely as “internal liability.”

Practical implication: a counterparty should still manage risk by requesting relevant resolutions as a condition precedent, and lack of required corporate approval may have consequences beyond internal liability – depending on the statutory basis and the factual situation.

Exception 2: Representation cannot be effectively restricted towards third parties beyond the statute

A company may disclose a representation clause in KRS, but cannot generally create “hidden” external restrictions that would be effective against third parties acting in good faith. This is closely connected with KRS publicity and reliance principles under the Act on the National Court Register (ustawa o Krajowym Rejestrze Sądowym) [2].

Practical implication: if KRS states joint representation, the counterparty should not accept a signature of a single board member based only on internal emails, powers of attorney, or an unsigned “board decision.” Conversely, if KRS states single representation, insisting on “two signatures as a policy” is a business choice, not a legal necessity.

Exception 3: Special rules apply for contracts with a management board member

When a contract is concluded between the company and a management board member (or when the company is in a dispute with a board member), Polish law requires special representation to avoid conflict of interest. For a sp. z o.o. this is regulated in Art. 210 of the Commercial Companies Code; for an S.A. see Art. 379 [1]. Typically, the company is represented by the supervisory board or a proxy appointed by a shareholders’ resolution (in a sp. z o.o.).

Practical implication: standard board signatures may be invalid in “director/board member self-dealing” scenarios. This point is frequently missed in intra-group agreements, management service agreements, and settlements.

Proxy vs director signing Poland – management board vs prokura vs power of attorney

Understanding delegation tools is essential for operational continuity.

• Management board member – signs according to the KRS representation clause.
• Commercial proxy (prokurent) – a statutory form of proxy under the Polish Civil Code (Art. 109¹-109⁹) with broad authority, disclosed in KRS, often used for joint representation with a board member [3].
• Attorney-in-fact (pełnomocnik) – a contractual power of attorney under the Civil Code (Art. 95-109), not necessarily disclosed in KRS, with scope defined in the POA; may require a specific form depending on the underlying act (e.g., a power of attorney to conclude a contract in the form of a notarial deed must itself be granted in the form of a notarial deed) [3].

Risk note (corrected): a prokurent’s authority is broad but not unlimited. Under the Civil Code, the disposal of an enterprise or the performance of a legal act by which an enterprise is given for temporary use, as well as the disposal and encumbrance of real estate, require a separate power of attorney (pełnomocnictwo szczególne) [3]. Other form requirements may also apply depending on the intended act.

Practical checklist for verifying representation before signing

1. Check KRS – confirm current board composition and the representation clause.
2. Match signatures to the clause – verify whether joint signatures are required.
3. Verify prokura (if used) – ensure the prokurent is registered and the type of prokura matches the signing model.
4. Assess conflicts – if the counterparty is also a board member, apply Art. 210/379 pathway.
5. Confirm form requirements – notarial deed, notarized signatures, or apostille/legalization may be needed depending on the transaction.

This is informational material, not legal advice. For a representation review aligned with the transaction structure and KRS entries, contact us at Lawyersinpoland.com by Kopeć & Zaborowski.

FAQ – Board Representation Rules: Single vs Joint Representation Explained

1) What does “company representation Poland” mean in practice?

It determines who can make legally binding declarations and sign agreements on behalf of a company, primarily based on the representation clause disclosed in KRS and the Commercial Companies Code [1], [2].

2) Is joint representation sp z oo common, and what is the usual model?

It is commonly used. Typical models require two board members acting jointly or one board member together with a registered commercial proxy (prokurent) [1], [3].

3) Who can sign contracts Poland company if one board member is absent?

If KRS provides joint representation, the absent signature cannot be “replaced” informally. Options include appointing an additional board member, granting prokura (if aligned with the model), or using a properly scoped power of attorney – depending on the representation clause and the intended act.

4) Can a company impose representation limits Poland that bind third parties?

As a rule, internal restrictions (e.g., approvals, limits) do not affect third parties, while external representation is determined by KRS and statutory rules. Specific statutory exceptions (including cases where the law requires a corporate resolution for a given act) and factual circumstances may apply [1], [2].

5) What is the difference between proxy vs director signing Poland?

A director (board member) represents the company under KRS. A commercial proxy (prokurent) is a statutory proxy with broad authority registered in KRS. A standard attorney-in-fact acts under a contractual POA with defined scope and may not appear in KRS [3].

6) Are special rules triggered when contracting with a management board member?

Yes. For a sp. z o.o. the company is represented under Art. 210 CCC; for an S.A. under Art. 379 CCC. Typically, a supervisory board or a proxy appointed by shareholders is required [1].

7) Does an incorrect signature always invalidate the contract?

Not always, but it creates significant risk. The outcome depends on the type of defect and whether confirmation (ratification) mechanisms apply under Polish civil law and the specific transaction context (in particular, rules on acting without or beyond authority) [3].

Bibliography

• [1] Act of 15 September 2000 – Commercial Companies Code (Kodeks spółek handlowych), in particular Art. 17, Art. 201, Art. 205, Art. 210, Art. 230, Art. 368, Art. 373, Art. 379, Art. 393.
• [2] Act of 20 August 1997 on the National Court Register (ustawa o Krajowym Rejestrze Sądowym).
• [3] Act of 23 April 1964 – Civil Code (Kodeks cywilny), in particular Art. 95-109 and Art. 109¹-109⁹ (prokura).